FDA Approved: ORPHENADRINE CITRATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for orphenadrine citrate submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasm
• Musculoskeletal Pain

Drugs mentioned

• Orphenadrine citrate (Orphenadrine citrate)

Snippet

SUPPL AP for ORPHENADRINE CITRATE (ORPHENADRINE CITRATE)